Management tracks: BioMarin's first chief scientific strategy officer; plus Ascletis, Grail, Aerie and more

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) promoted Lon Cardon to the newly created role of chief scientific strategy officer from CSO. Prior to BioMarin, Cardon was SVP of alternative discovery and development and head of target sciences at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).

Antiviral and cancer company Ascletis Pharma Inc. (HKSE:1672) hired Handan He as CSO. She was global head of computational, biopharmaceutics and translational PK/PD at the Novartis Pharmaceuticals Corp. affiliate of Novartis AG (NYSE:NVS; SIX:NOVN).

Early cancer detection company Grail Inc. hired Matthew Young as COO and CFO, effective Oct. 28. Young was EVP and CFO at Jazz Pharmaceuticals plc (NASDAQ:JAZZ).

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) said that A. Brian Davis will join the dermatology company as CFO, succeeding Chris Degnan, who is resigning from the company, effective Oct. 18, to pursue an opportunity in oncology. Davis was CFO of Strongbridge Biopharma plc (NASDAQ:SBBP).

Opthalmic company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) hired Charlene Davis as VP and chief compliance officer. She was associate VP and head of healthcare compliance North America for Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA).

Lung cancer diagnostic company Biodesix Inc. hired James Jett to share the position of CMO with Steven Springmeyer. Jett was CMO at Oncimmune Holdings plc (LSE:ONC).

Nurix Therapeutics Inc., which focuses on targeted protein degradation, appointed board member David Lacey chairman while adding Lori Kunkel and Julia Gregory to the board. Kunkel served on the board of Loxo Oncology Inc. until its sale to Eli Lilly and Co. (NYSE:LLY). Gregory is chair and CEO of Isometry Advisors Inc.

Therapeutic toxin company Aeon Biopharma Inc., a subsidiary of Alphaeon Corp., hired Chris Carr as CFO and Scott Akamine as general counsel. Carr was CFO, EVP of finance and IT, and a board member of Dendreon Pharmaceuticals LLC. Akamine was VP and associate general counsel at CoreLogic Inc. (NYSE:CLGX).

Health tech company Castor EDC hired Frank Cesaro as head of global sales. He was head of sales at Zocdoc Inc. Castor's electronic data capture platform enables real-time, cloud-based recording and integration of medical research data including data derived from sources including clinicians, patients and wearable devices.

Relay Therapeutics Inc., which is developing therapies that modulate protein conformation, appointed Jami Rubin to the board. She is a partner at PJT Partners.

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE